We will share with you what we have told those patients, focusing on answering some of the key questions
This sterile solution gives reliable results in every experiment
OASIS trials: establishing effective doses Phase 2 OASIS 1 findings: Tested multiple dose levels: 0.3mg, 0.6mg, 1.2mg, 2.4mg, 4.5mg weekly Duration: 26 weeks Primary endpoint: Weight loss at each dose Dose-response results: 0.3mg weekly: ~4% body weight loss 0.6mg weekly: ~6% body weight loss 1.2mg weekly: ~8% body weight loss 2.4mg weekly: ~10% body weight loss 4.5mg weekly: ~12% body weight loss Key insight: Clear dose-response relationship
Additional charges may be applied at that time
Patients often explore this program for recovery support, joint support, tissue support, and wellness-focused care
Aim the stream down the inside wall of the peptide vial instead of blasting the powder directly